Articles tagged "Outcome"

2022 American Transplant Congress
The Development of a Scientific Registry of Transplant Recipients Data Query Tool: A Human-Centered Design Process
C. Schaffhausen¹, A. Hart², C. S. Zinner³, A. K. Israni², J. Snyder¹
¹Hennepin Healthcare Research Institute, Minneapolis, MN, ²Hennepin Healthcare (HHS) / University of Minnesota (UMN), Minneapolis, MN, ³Accenture Federal Services, Washington, DC
*Purpose: The Scientific Registry of Transplant Recipients (SRTR) provides national transplant data in various forms, including the OPTN/SRTR Annual Data Report (ADR). The ADR includes…
2022 American Transplant Congress
Performance of Kidney Transplantation in a Resource-Poor Setting of Southeast Nigeria- A Review of the First Ten Cases
C. G. Okwuonu¹, O. J. Chimezie², G. O. Achor³, N. M. Erondu⁴, C. Ralph-Iheke⁵, S. Alhassan⁶
¹INTERNAL MEDICINE/NEPHROLOGY, Federal Medical Centre, Umuahia, Nigeria, ²OPTOMETRY, Federal Medical Centre, Umuahia, Nigeria, ³SURGERY/UROLOGY, Federal Medical Centre, Umuahia, Nigeria, ⁴ANAESTHESIA, Federal Medical Centre, Umuahia, Nigeria, ⁵NURSING SERVICES DIVISION, Federal Medical Centre, Umuahia, Nigeria, ⁶SURGERY/UROLOGY, Aminu Kano Teaching Hospital, Kano, Nigeria
*Purpose: To assess complication and survival after performance of kidney transplantation in a resource poor setting in Southeast Nigeria*Methods: A retrospective review of transplant registers…
2022 American Transplant Congress
Lung Transplantation For COVID Acute Respiratory Distress Syndrome: A Pediatric And Adult Case Series
C. Arendale¹, D. Kumar², P. S. Garcha³, C. Kutac⁴, G. Loor¹, A. Rana¹, J. Goss¹, N. Galvan¹
¹Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, ²Department of Biochemistry, Baylor College of Medicine, Houston, TX, ³Department of Medicine, Baylor College of Medicine, Houston, TX, ⁴Baylor St. Luke’s Medical Center, Houston, TX
*Purpose: Lung transplantation (LTx) has been shown to be a viable treatment for irreversible lung disease caused by COVID-19. Given the limited data on the…
2022 American Transplant Congress
Transjugular Intrahepatic Portosystemic Shunt Placement is Associated with Increased All-Cause and Cardiac Mortality in Those Undergoing Liver Transplant for Nonalcoholic Steatohepatitis
D. U. Lee¹, J. Han², J. Kwon², K. Chang², G. Fan², K. Lee¹, N. Urrunaga³, C. Bhati¹, D. Maluf³, K. Shetty³
¹Department of Gastroenterology and Hepatology, University of Maryland, Baltimore, MD, ²Tufts Medical Center, Boston, MA, ³University of Maryland, Baltimore, MD
*Purpose: Since the effect of transjugular intrahepatic portosystemic shunt (TIPS) on post LT outcomes is not well understood, we undertook this analysis of a large…
2022 American Transplant Congress
Outcomes After Covid-19 Infection in Transplant Recipients
K. L. Freels¹, K. Saharia², J. Baddley², N. Costa³, S. Niederhaus⁴
¹University of Maryland School of Medicine, Baltimore, MD, ²Medicine, University of Maryland School of Medicine, Baltimore, MD, ³Medicine, Georgetown University, Washington, DC, ⁴Surgery, University of Maryland School of Medicine, Baltimore, MD
*Purpose: The purpose of this study is to evaluate outcomes of readmission, rejection, graft dysfunction, graft failure, and death in SOT recipients (SOTR) after COVID-19…
2022 American Transplant Congress
Outcomes and Complications of Covid-19 in Pediatric Solid Organ Transplant Patients
L. Ott, P. Scalise, B. Kimball, A. G. Cuenca
Department of Surgery, Boston Children's Hospital, Boston, MA
*Purpose: The purpose of the study was to examine the clinical course, outcomes, and complications of COVID-19 in pediatric solid organ transplant patients from a…
2022 American Transplant Congress
High-Level Pre-Transplant C-Peptide Among T2d Recipients of Simultaneous Pancreas and Kidney Transplants is Associated with Reduced Pancreatic Graft Function
S. Parajuli, D. Mandelbrot, D. Aufhauser, D. Kaufman, J. Odorico
University of Wisconsin, Madison, WI
*Purpose: Among selected patients with end-stage renal disease (ESRD) and type 2 diabetes (T2DM), simultaneous pancreas and kidney (SPK) transplants can be an effective option,…
2022 American Transplant Congress
Renal Function at Five Years from a Randomized Multicenter Trial of Belatacept-Based CNI Free and Early Steroid Withdrawal Immunosuppression
E. Yanqui¹, H. Hames¹, A. R. Shields¹, T. Shi¹, A. L. Christianson¹, J. Kremer², A. Govil¹, R. R. Alloway¹, E. S. Woodle¹
¹University of Cincinnati, Cincinnati, OH, ²Christ Hospital, Cincinnati, OH
*Purpose: BENEFIT and BENEFIT EXT trials have demonstrated that belatacept-based immunosuppression was associated with improved long term renal allograft function compared to cyclosporine-based immunosuppression. Similar…
2022 American Transplant Congress
Monitoring Efficacy of Tocilizumab Treatment for Chronic Antibody Mediated Rejection (cAMR) in Kidney Transplants Using Donor-Derived Cell-Free DNA (dd-cf-DNA)
J. Tang¹, A. Vo¹, E. Huang¹, X. Zhang², N. Ammerman¹, A. Peng¹, R. Najjar¹, S. Sethi¹, K. Lim¹, M. Gillespie¹, N. Badash¹, S. Jordan¹
¹Comprehensive Transplant Center, Cedars Sinai Medical Ctr, Los Angeles, CA, ²HLA Laboratory, Cedars Sinai Medical Ctr, Los Angeles, CA
*Purpose: IL-6/IL-6R have emerged as important targets for treating cAMR. Recent data show that long-term treatment can stabilize eGFR, reduce DSAs and result in a…
2022 American Transplant Congress
Portal Vein Thrombosis and DCD Liver Transplantation: Dangerous Combination or Clinical Opportunity?
E. Calderon¹, Y. Chang², P. Lu¹, A. M. Durant³, D. Derakshani⁴, M. L. Anderson⁴, E. R. Luque Villa², C. Jadlowiec², K. Reddy², A. Moss², A. K. Mathur²
¹General Surgery, Mayo Clinic, Phoenix, AZ, ²Mayo Clinic, Phoenix, AZ, ³Urology, Mayo Clinic, Phoenix, AZ, ⁴Mayo Clinic Alix School of Medicine, Phoenix, AZ
*Purpose: Individually, recipient portal vein thrombosis (PVT) and donation after circulatory death (DCD) allografts are associated with a higher risk of poor deceased donor liver…